Investors Unlocking the big pharma opportunity in cannabis Before large pharmaceutical players dive deep into cannabis, we believe a few milestones must be achieved.
Investors Stable genetics and the case for cannabis seed specialists Stable genetics are a key obstacle facing consistent cannabis growing in the short term.
Investors How BioLumic switches on the growing power of ultraviolet light for cannabis producers Behind Canopy Rivers' investment in agtech company BioLumic.
Investors How ZeaKal’s trait technology plans to supercharge hemp growth Behind Canopy Rivers’ Investment of US$10 Million in ZeaKal, Inc.